De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy.
J Am Acad Dermatol
; 91(4): 720-722, 2024 Oct.
Article
in En
| MEDLINE
| ID: mdl-38844009
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Kidney Transplantation
/
Abatacept
/
Immunosuppressive Agents
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Am Acad Dermatol
/
J. Am. Acad. Dermatol
/
Journal of the American Academy of dermatology
Year:
2024
Document type:
Article
Country of publication:
Estados Unidos